Linda A. DiMeglio - Concepedia

Author

Linda A. DiMeglio

Indiana University – Purdue University Indianapolis ORCID

Also Known As

Alan Schultz, Anna Neyman, Ashley Eason, Craig Kollman, DiMeglio, L.A., DiMeglio, Linda A, Diana Olivos, Elaine Apperson, Farah A. Meah, Fitzgibbon, Margret L.

468

Publications

25.7K

Citations

H-Index

169

Concepts

All Affiliations

Indiana University – Purdue University Indianapolis Indiana University School of Medicine Yale University Jaeb Center for Health Research Riley Hospital for Children

About

Linda A. DiMeglio is an author at Indiana University – Purdue University Indianapolis specializing in medicine, diabetes, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	57	5.7K
2	Public Health	19	24	2K
3	Health Sciences	7	7	555
4	Education	6	6	403
5	Engineering	1	1	16

Linda A. DiMeglio

158

Publications

18.1K

Citations

H-Index

Page 1

	Year	Citations
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018 Nicole C. Foster, Roy W. Beck, Kellee M. Miller, Diabetes Technology & Therapeutics	2019	1.8K
Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry Kellee M. Miller, Nicole C. Foster, Roy W. Beck, Diabetes Care	2015	1.2K
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes Kevan C. Herold, Brian N. Bundy, S. Alice Long, New England Journal of Medicine	2019	1K
ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes Linda A. DiMeglio, Carlo L. Acerini, Ethel Codner, Pediatric Diabetes Diabetes ManagementYoung AdultsGlucose MonitoringCardiovascular DiseaseDiabetes	2018	595
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial Tihamer Orban, Brian N. Bundy, Dorothy J. Becker, The Lancet Diabetes ManagementDiabetesCo-stimulation ModulationDiabetic NeuropathyPlacebo-controlled Trial	2011	589
Most Youth With Type 1 Diabetes in the T1D Exchange Clinic Registry Do Not Meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes Clinical Guidelines Jamie Wood, Kellee M. Miller, David M. Maahs, Diabetes Care	2013	409
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial Diane K. Wherrett, Brian N. Bundy, Dorothy J. Becker, The Lancet VaccinationDiabetes ManagementAutoimmune DiseaseInsulin ManagementDiabetes	2011	364
Racial-Ethnic Disparities in Management and Outcomes Among Children With Type 1 Diabetes Steven M. Willi, Kellee M. Miller, Linda A. DiMeglio, PEDIATRICS	2015	354
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials Antoinette Moran, Brian N. Bundy, Dorothy Becker, The Lancet InflammationMetabolic SyndromeType 1Diabetes ManagementAutoimmune Disease	2013	351
Global Consensus Recommendations on Prevention and Management of Nutritional Rickets Craig F. Munns, Nick Shaw, Máiréad Kiely, Hormone Research in Paediatrics	2016	345

Page 1